| Application no. and date | 00902415.9 (espacenet) (Federated) (European Patent Register), 20000114 | | Patent/reg. no. and date | DK/EP 1143989, 20061213 | | Publication date | 20011017 | | Priority no. and date | US 116380 P, 19990114, US 132017 P, 19990430, US 175365 P, 20000110 | | EP pub. no. and date |
EP 1143989 20011017 | | Effective date | | | Applicant/owner | Amylin Pharmaceuticals, LLC, 9360 Towne Centre Drive
San Diego, CA 92121, US,
AstraZeneca Pharmaceuticals LP, 1800 Concord Pike
Wilmington, DE 19850-5437, US | | Applicant ref. no. | P80602775DK00E | | Inventor | YOUNG, Andrew, P.O. Box 60591
Point Loma, CA 92166, US,
GEDULIN, Bronislava, 12825 Stebick Court
San Diego, CA 92131, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 38/17 (2006.01) , A61P 3/10 (2006.01) | | Title | Exendiner til glucagonundertrykkelse | | Int. application no. | US2000000942 | | Int. publication no. | WO2000041548 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
